We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $6.66B
1-Year Est. Return 360.84%
This Fund
S&P 500
This Quarter Est. Return
-21.79%
1 Year Est. Return
+360.84%
3 Year Est. Return
+1,707.27%
5 Year Est. Return
+3,210.42%
10 Year Est. Return
+53,055.89%
AUM
$2.63B
AUM Growth
-$1.11B
Cap. Flow
-$123M
Cap. Flow %
-4.66%
Top 10 Hldgs %
51.48%
Holding
146
New
29
Increased
20
Reduced
29
Closed
45

Top Buys

Rank Stock Value
1
SLDB icon
Solid Biosciences
SLDB
+$123M
2
AMRN
Amarin Corp
AMRN
+$77.8M
3
IOVA icon
Iovance Biotherapeutics
IOVA
+$47.7M
4
ALLO icon
Allogene Therapeutics
ALLO
+$41M
5
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
+$39M

Top Sells

Rank Stock Value
1
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$72M
2
CORI
Corium International, Inc.
CORI
+$60.5M
3
ECYT
Endocyte, Inc. Common Stock
ECYT
+$43.4M
4
ISRG icon
Intuitive Surgical
ISRG
+$41.6M
5
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$37.2M

Sector Composition

Rank Sector Weight
1 Healthcare 97.94%
2 Miscellaneous 1.24%
3 Consumer Staples 0.68%
4 Financials 0.08%
5 Consumer Discretionary 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABEO icon
76
Abeona Therapeutics
ABEO
$313M
$1.27M 0.05%
7,232
-2,386
-25% -$520K
ABEOW
77
DELISTED
Abeona Therapeutics Inc Warrant
ABEOW
$1.27M 0.05%
659,636
– –
CDNA icon
78
CareDx
CDNA
$2.72B
$1.04M 0.04%
44,128
-216,548
-83% -$5.56M
ADVM
79
DELISTED
Adverum Biotechnologies
ADVM
$960K 0.04%
+30,000
New +$1.22M
STLA icon
80
Stellantis
STLA
$14.8B
$894K 0.03%
62,000
– –
IVC
81
DELISTED
Invacare Corporation
IVC
$860K 0.03%
200,000
– –
ALNA
82
DELISTED
Allena Pharmaceuticals
ALNA
$704K 0.03%
132,300
-117,700
-47% -$1.01M
RACE icon
83
Ferrari
RACE
$71.5B
$610K 0.02%
6,200
– –
VCEL icon
84
Vericel Corp
VCEL
$2.03B
$488K 0.02%
28,090
+879
+3% +$13.2K
TNDM icon
85
Tandem Diabetes Care
TNDM
$1.13B
$479K 0.02%
+12,844
New +$454K
DXCM icon
86
DexCom
DXCM
$32.6B
$442K 0.02%
+14,932
New +$474K
AMED
87
DELISTED
Amedisys
AMED
$422K 0.02%
+3,672
New +$433K
GKOS icon
88
Glaukos
GKOS
$10.1B
$417K 0.02%
+7,466
New +$449K
ZGNX
89
PUT
DELISTED
Zogenix, Inc.
ZGNX
$410K 0.02%
+200,000
New +$8.19M
STAA icon
90
STAAR Surgical
STAA
$1.13B
$405K 0.02%
+12,953
New +$505K
IMMU
91
CALL
DELISTED
Immunomedics Inc
IMMU
$308K 0.01%
+200,000
New +$3.97M
SIBN icon
92
SI-BONE Inc
SIBN
$831M
$307K 0.01%
+15,000
New +$284K
ADYX
93
DELISTED
Adynxx Inc
ADYX
$214K 0.01%
19,122
-51,444
-73% -$625K
VCNX
94
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$190K 0.01%
238
– –
OTLKW
95
DELISTED
Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022
OTLKW
$72K ﹤0.01%
+420,875
New +$53.1K
ONCS
96
DELISTED
OncoSec Medical Incorporated
ONCS
$32K ﹤0.01%
227
– –
SLDB icon
97
CALL
Solid Biosciences
SLDB
$897M
$14K ﹤0.01%
+122
New +$57.4K
AQST icon
98
Aquestive Therapeutics
AQST
$604M
– –
-1,150,000
Closed -$20.1M
ARVN icon
99
Arvinas
ARVN
$540M
– –
-125,000
Closed -$2.11M
BLFS icon
100
BioLife Solutions
BLFS
$1.78B
– –
-29,376
Closed -$514K
2 3
4
5 6

Similar funds

QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.59B AUM 31.9% 1-Year Est. Return
KGA
K5 Global Advisor Miami Beach, Florida $6.59B AUM
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

Perceptive Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, Perceptive Advisors held 146 positions worth $2.63B, down 30% from $3.74B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Perceptive Advisors withdrew a net $123M in Q4 2018, closing 45 positions and reducing 29 holdings. Its most notable exit was Corium International, Inc., an estimated $60.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 93% a quarter earlier, followed by Miscellaneous and Consumer Staples.

Against the trend, Perceptive Advisors opened a new position in Solid Biosciences worth $105M.

  • Perceptive Advisors's largest Q4 2018 buy was Solid Biosciences: 261,815 shares worth $105M.
  • Perceptive Advisors added most to Amarin Corp in Q4 2018, an estimated $77.8M increase.
  • Perceptive Advisors's biggest Q4 2018 reduction was Alnylam Pharmaceuticals, cutting an estimated $72M.
  • Perceptive Advisors fully exited Corium International, Inc. in Q4 2018, selling an estimated $60.5M.
  • Perceptive Advisors's ten largest holdings make up 51% of its $2.63B portfolio in Q4 2018.
  • Perceptive Advisors opened 29 new positions and closed 45 in Q4 2018.
  • Perceptive Advisors's portfolio value fell 30% quarter-over-quarter to $2.63B.

Based on Perceptive Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.